Doxorubicin-docetaxel sequential schedule: results of front-line treatment in advanced breast cancer.
Palmeri S, Leonardi V, Tamburo De Bella M, Morabito A, Vaglica M, Accurso V, Ferraù F, Failla G, Agostara B, Massidda B, Valenza R, Fanelli M, Gasparini G.
Palmeri S, et al. Among authors: valenza r.
Oncology. 2002;63(3):205-12. doi: 10.1159/000065466.
Oncology. 2002.
PMID: 12381898
Clinical Trial.